Hydrochloric Acid

Hydrochloric Acid

SCHEMBL150721

CCCCCCCC[Al].Cl.Cl

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.57
THRB P10828 1/20 0.57
DNM1 Q05193 10/20 0.56
ALDH1A1 P00352 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
EPHX1 P07099 1/20 0.50
LMNA P02545 2/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1959135 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1MEN1
Hydrochloric Acid SCHEMBL6813217 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1MEN1
Hydrochloric Acid SCHEMBL1850499 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1MEN1
Hydrochloric Acid SCHEMBL1855223 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1MEN1
Hydrochloric Acid SCHEMBL1538975 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1MEN1
Hydrochloric Acid SCHEMBL7179959 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1MEN1
Hydrochloric Acid SCHEMBL8735592 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1MEN1
Hydrochloric Acid SCHEMBL11652942 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1MEN1
Hydrochloric Acid SCHEMBL6563761 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1MEN1
Hexane SCHEMBL11105002 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 780 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117924601-B Copolymer, preparation method thereof, vulcanized rubber and application thereof 中国石油化工股份有限公司 2025-05-06 CN claimed
CN-119192498-A Ethylene-butadiene polymer, process for producing the same, and vulcanized rubber 中国石油化工股份有限公司 2024-12-27 CN claimed
CN-119192499-A Ethylene-butadiene polymer, process for producing the same, and vulcanized rubber 中国石油化工股份有限公司 2024-12-27 CN claimed
CN-119192500-A Ethylene-isoprene polymer, preparation method thereof and vulcanized rubber 中国石油化工股份有限公司 2024-12-27 CN claimed
WO-2024088247-A1 COPOLYMER, PREPARATION METHOD THEREFOR, VULCANIZED RUBBER AND USE THEREOF 中国石油化工股份有限公司 2024-05-02 WO claimed
CN-117924601-A Copolymer, preparation method thereof, vulcanized rubber and application thereof 中国石油化工股份有限公司 2024-04-26 CN claimed
US-11427700-B2 Method of manufacturing rubber composition KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2022-08-30 US claimed
US-9856337-B2 Polymerization catalysts IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-01-02 US claimed
US-20170275402-A1 POLYMERIZATION CATALYSTS IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2017-09-28 US claimed
US-7468417-B2 Method of preparing cyclic olefin copolymer having controlled gel contents KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2008-12-23 US claimed
US-20070060730-A1 METHOD OF PREPARING CYCLIC OLEFIN COPOLYMER HAVING CONTROLLED GEL CONTENTS KOREA KUMHO PETROCHEMICAL CO., LTD./NEW KOREA INTE (KR) 2007-03-15 US claimed
US-6093674-A CATALYST FOR GAS PHASE POLYMERIZATION OF CONJUGATED DIENES WITH ELEVATED CONTENT OF LATERAL DOUBLE BONDS BAYER AG (DE) 2000-07-25 US claimed
US-3960765-A REDUCING TITANIUM TETRACHLORIDE WITH AN ORGANOALUMINUM COMPOUND, COMPLEXING AGENT SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-06-01 US claimed
US-20260139129-A1 Polyethylene Resin Composition SONG, Christine Jisoo (KR) 2026-05-21 US disclosed
EP-3969490-B1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND TIRE COMPONENTS BRIDGESTONE CORP (JP) 2026-03-25 EP disclosed
US-20250389555-A1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) 2025-12-25 US disclosed
US-4066683-A PROCESS FOR THE PREPARATION OF DIAMINOMALEONITRILE NIPPON CHEMICALS CO., LTD. (JA) 1978-01-03 US disclosed
US-4057681-A SOLUTION EXXON RESEARCH & ENGINEERING CO. (US) 1977-11-08 US disclosed
US-4031300-A High molecular weight, high unsaturation isobutylene-cyclopentadiene copolymers EXXON RESEARCH AND ENGINEERING COMPANY (US) 1977-06-21 US disclosed
US-3960765-A REDUCING TITANIUM TETRACHLORIDE WITH AN ORGANOALUMINUM COMPOUND, COMPLEXING AGENT SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260139129-A1 Polyethylene Resin Composition MACF1, LBR, SMCHD1 TSHR 1067/4885THRB 3202/4885DNM1 1776/4885
US-20170275402-A1 POLYMERIZATION CATALYSTS SIK2, SIK3, SGK2 TSHR 4821/4885THRB 4662/4885DNM1 2237/4885
US-20250389555-A1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS MALT1, INO80C, RTCB TSHR 1694/4885THRB 529/4885DNM1 4219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.